Pharma group Hikma looks to take advantage as Novo Nordisk’s Wegovy and Ozempic start to go off patent next year ...

Very few people are currently being prescribed drugs for weight loss on the NHS in Scotland, research by BBC Scotland News ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

Hikma launched liraglutide, a generic version of an earlier Novo Nordisk weight loss drug, in the US in December. Liraglutide, which Novo sells as Victoza for diabetes and Saxenda for weight loss, has ...

Also, so did another GLP-1 compound called liraglutide, which is sold under the brand names Victoza and Saxenda ... Generally speaking, drug makers price very aggressively. They tend to increase ...

Prices, and the value of medicines ... allowing patients to record ingestion and share data with healthcare professionals. 7. Saxenda – are drugs really the answer to obesity?

Both companies have seen a monumental rise in share price since the successful commercial ... loss product that Novo Nordisk had launched, Saxenda (liraglutide), which had been approved by the ...

Since 2022, a third drug, liraglutide, has been approved under the name of Saxenda. But all of these ... they were expensive at first - but then the price started to fall. While they could only ...

Novo Nordisk (NVO) stock rebounds after Kepler Cheuvreux upgrades to Buy following a 42% stock drop over the past year. Read ...